Consortium Member of the Month

Our consortium member of the month for the month of June goes to Jamie Galarza-Cornejo from Mount Sinai!

Jamie Galarza-Cornejo

Clinical Research Coordinator II

We are proud to recognize Jamie Galarza-Cornejo as the MPN-RC Member of the Month. Since joining the Research Consortium team as a Clinical Research Coordinator in January, Jamie has played a key role in ensuring a seamless transition of patient consenting and sample collection for our tissue banking study. Jamie has demonstrated exceptional attention to detail by proactively identifying and resolving discrepancies within the REDCap database, while also ensuring that annual specimen collections are completed within the required study window. Her dedication, organization, and commitment to research excellence have made a meaningful impact on the team and the success of the study.

Nominated by: Victoria Rivera

Jamie, thank you so much for all of the phenomenal work you have done for the consortium.

Keep up the great work!

MPN-RC Monthly Publication

Title: Acute Myeloid Leukemia, Myelodysplasia-Related(AML-MR), With del(5q) and Double Minutes ContainingChromosomal Segment 11q24 Leading to Amplifcation andExpression of FLI1

Author(s): Satomi Hiya, Joseph Tripodi, John Mascarenhas, Alina Dulau Florea, Vesna Najfeld

Full Article

ASH Conference 2025

(Left to Right: Gaby Bello, Carly Sullivan, Ashley Yu) The Mount Sinai group from the MPN Research Consortium attended the American Society of Hematology 2025 Conference in Orlando, Florida.
Dr. Xiaoli Wang presents her ASH abstract “Therapy resistance and disease relapse in patients with MPN-blast phase are associated with clonal evolution and transcriptomic changes in MPN- blast phase stem cells”. View the abstract here!
Dr. Andrew Kuykendall presents his ASH abstract “A phase 2 study of canakinumab in patient with myelofibrosis: Results from part 1”. View the abstract here!
(Left to Right: Md. Babu Mia, Noushin Rahnamay, Dr. Bridget Marcellino, and Dr. Raajit Rampal) The Mount Sinai and Memorial Sloan Kettering group from the MPN Research Consortium attended the American Society of Hematology 2025 Conference in Orlando, Florida.

ASH Abstracts

Marina Kremyanskaya, MD,PhD

Phase II study of reparixin in patients with myelofibrosis. myeloproliferative neoplasms research consortium (MPN-RC) 120 trial

Full ASH Abstract
John Crispino, PhD,MBA

Menin inhibition as a new therapeutic option for the myeloproliferative neoplasms

Full Ash Abstract
John Mascarenhas, MD

Bone marrow adipocytes (BMA) as a novel biomarker of molecular response in patients with essential thrombocythemia (ET) and polycythemia vera (PV) treated with pegylated interferon alfa-2A

Full ASH Abstract
Andrew Kuykendall, MD

A phase 2 study of canakinumab in patient with myelofibrosis: Results from part 1

Full Ash Abstract
Min Lu, MD,PhD

Myelofibrosis stem cell fitness requires microenvironmental cell interactions

Full ASH Abstract
Xiaoli Wang, MD,PhD

Therapy resistance and disease relapse in patients with MPN-blast phase are associated with clonal evolution and transcriptomic changes in MPN- blast phase stem cells

Full Ash Abstract
MD Babu Mia, PhD

Single cell transcriptional profiling reveals distinct subsets of human megakaryocytes in myelofibrosis

Full ASH Abstract